Reversal of lidocaine effects on sodium currents by isoproterenol in rabbit hearts and heart cells
We demonstrated recently that isoproterenol enhanced the cardiac voltage-dependent sodium currents (INa) in rabbit ventricular myocytes through dual G-protein regulatory pathways. In this study, we tested the hypothesis that isoproterenol reverses the sodium channel blocking effects of class I antia...
Saved in:
Published in | The Journal of clinical investigation Vol. 91; no. 2; pp. 693 - 701 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Ann Arbor, MI
American Society for Clinical Investigation
01.02.1993
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We demonstrated recently that isoproterenol enhanced the cardiac voltage-dependent sodium currents (INa) in rabbit ventricular myocytes through dual G-protein regulatory pathways. In this study, we tested the hypothesis that isoproterenol reverses the sodium channel blocking effects of class I antiarrhythmic drugs through modulation of INa. The experiments were performed in rabbit ventricular myocytes using whole-cell patch-clamp techniques. Reversal of lidocaine suppression of INa by isoproterenol (1 microM) was significant at various concentrations of lidocaine (20, 65, and 100 microM, P < 0.05). The effects of isoproterenol were voltage dependent, showing reversal of INa suppression by lidocaine at normal and hyperpolarized potentials (negative to -80 mV) but not at depolarized potentials. Isoproterenol enhanced sodium channel availability but did not alter the steady state activation or inactivation of INa nor did it improve sodium channel recovery in the presence of lidocaine. The physiological significance of the single cell INa findings were corroborated by measurements of conduction velocities using an epicardial mapping system in isolated rabbit hearts. Lidocaine (10 microM) significantly suppressed epicardial impulse conduction in both longitudinal (theta L, 0.430 +/- 0.024 vs. 0.585 +/- 0.001 m/s at baseline, n = 7, P < 0.001) and transverse (theta T, 0.206 +/- 0.012 vs. 0.257 +/- 0.014 m/s at baseline, n = 8, P < 0.001) directions. Isoproterenol (0.05 microM) significantly reversed the lidocaine effects with theta L of 0.503 +/- 0.027 m/s and theta T of 0.234 +/- 0.015 m/s (P = 0.014 and 0.004 compared with the respective lidocaine measurements). These results suggest that enhancement of INa is an important mechanism by which isoproterenol reverses the effects of class I antiarrhythmic drugs. |
---|---|
AbstractList | We demonstrated recently that isoproterenol enhanced the cardiac voltage-dependent sodium currents (INa) in rabbit ventricular myocytes through dual G-protein regulatory pathways. In this study, we tested the hypothesis that isoproterenol reverses the sodium channel blocking effects of class I antiarrhythmic drugs through modulation of INa. The experiments were performed in rabbit ventricular myocytes using whole-cell patch-clamp techniques. Reversal of lidocaine suppression of INa by isoproterenol (1 microM) was significant at various concentrations of lidocaine (20, 65, and 100 microM, P < 0.05). The effects of isoproterenol were voltage dependent, showing reversal of INa suppression by lidocaine at normal and hyperpolarized potentials (negative to -80 mV) but not at depolarized potentials. Isoproterenol enhanced sodium channel availability but did not alter the steady state activation or inactivation of INa nor did it improve sodium channel recovery in the presence of lidocaine. The physiological significance of the single cell INa findings were corroborated by measurements of conduction velocities using an epicardial mapping system in isolated rabbit hearts. Lidocaine (10 microM) significantly suppressed epicardial impulse conduction in both longitudinal (theta L, 0.430 +/- 0.024 vs. 0.585 +/- 0.001 m/s at baseline, n = 7, P < 0.001) and transverse (theta T, 0.206 +/- 0.012 vs. 0.257 +/- 0.014 m/s at baseline, n = 8, P < 0.001) directions. Isoproterenol (0.05 microM) significantly reversed the lidocaine effects with theta L of 0.503 +/- 0.027 m/s and theta T of 0.234 +/- 0.015 m/s (P = 0.014 and 0.004 compared with the respective lidocaine measurements). These results suggest that enhancement of INa is an important mechanism by which isoproterenol reverses the effects of class I antiarrhythmic drugs. We demonstrated recently that isoproterenol enhanced the cardiac voltage-dependent sodium currents (INa) in rabbit ventricular myocytes through dual G-protein regulatory pathways. In this study, we tested the hypothesis that isoproterenol reverses the sodium channel blocking effects of class I antiarrhythmic drugs through modulation of INa. The experiments were performed in rabbit ventricular myocytes using whole-cell patch-clamp techniques. Reversal of lidocaine suppression of INa by isoproterenol (1 microM) was significant at various concentrations of lidocaine (20, 65, and 100 microM, P < 0.05). The effects of isoproterenol were voltage dependent, showing reversal of INa suppression by lidocaine at normal and hyperpolarized potentials (negative to -80 mV) but not at depolarized potentials. Isoproterenol enhanced sodium channel availability but did not alter the steady state activation or inactivation of INa nor did it improve sodium channel recovery in the presence of lidocaine. The physiological significance of the single cell INa findings were corroborated by measurements of conduction velocities using an epicardial mapping system in isolated rabbit hearts. Lidocaine (10 microM) significantly suppressed epicardial impulse conduction in both longitudinal (theta L, 0.430 +/- 0.024 vs. 0.585 +/- 0.001 m/s at baseline, n = 7, P < 0.001) and transverse (theta T, 0.206 +/- 0.012 vs. 0.257 +/- 0.014 m/s at baseline, n = 8, P < 0.001) directions. Isoproterenol (0.05 microM) significantly reversed the lidocaine effects with theta L of 0.503 +/- 0.027 m/s and theta T of 0.234 +/- 0.015 m/s (P = 0.014 and 0.004 compared with the respective lidocaine measurements). These results suggest that enhancement of INa is an important mechanism by which isoproterenol reverses the effects of class I antiarrhythmic drugs. |
Author | REYNERTSON, S. I SHIBATA, E. F HON-CHI LEE MATSUDA, J. J MARTINS, J. B |
AuthorAffiliation | Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242 |
AuthorAffiliation_xml | – name: Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242 |
Author_xml | – sequence: 1 surname: HON-CHI LEE fullname: HON-CHI LEE organization: Univ. Iowa coll. medicine, dep. internal medicine, Iowa City IA 52242, United States – sequence: 2 givenname: J. J surname: MATSUDA fullname: MATSUDA, J. J organization: Univ. Iowa coll. medicine, dep. internal medicine, Iowa City IA 52242, United States – sequence: 3 givenname: S. I surname: REYNERTSON fullname: REYNERTSON, S. I organization: Univ. Iowa coll. medicine, dep. internal medicine, Iowa City IA 52242, United States – sequence: 4 givenname: J. B surname: MARTINS fullname: MARTINS, J. B organization: Univ. Iowa coll. medicine, dep. internal medicine, Iowa City IA 52242, United States – sequence: 5 givenname: E. F surname: SHIBATA fullname: SHIBATA, E. F organization: Univ. Iowa coll. medicine, dep. internal medicine, Iowa City IA 52242, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4632303$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/8381826$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkU1r3DAQhkVISTZJD_kBAR1KoQe3-rIlH3oIS5umBAohPQt5NG5UvNJWsgP591HYZWlOM8z7zBfvGTmOKSIhl5x95lyLLz_Xt5x3omVHZMXb1jRGSHNMVowJ3vRamlNyVspfxrhSrTohJ0YabkS3IsM9PmEubqJppFPwCVyISHEcEeZCU6Ql-bBsKCw5Y6yl4ZmGkrY5zVgLaaIh0uyGIcz0EV2uhIt-l1LAaSoX5N3opoLv9_Gc_P7-7WH9o7n7dXO7vr5rQPZmbhB72WrlOJgWWKeU0aNnSnceQGuBMIBnkjnwxovOMK6ZEb7vnWYIHaA8J193c7fLsEEP9drsJrvNYePys00u2LdKDI_2T3qywtRpvPZ_3Pfn9G_BMttNKK8fuIhpKVa3bSeYUhX8tAMhp1IyjocdnNlXP-zBj8pe_X_UgdwbUPUPe90VcNOYXYRQDpjqpJBMyhcmqJYw |
CODEN | JCINAO |
CitedBy_id | crossref_primary_10_1161_01_CIR_96_8_2701 crossref_primary_10_1111_j_1540_8159_1996_tb03409_x crossref_primary_10_1016_j_yjmcc_2016_08_011 crossref_primary_10_1111_nyas_14425 crossref_primary_10_1111_j_1469_7793_1999_0153o_x crossref_primary_10_1097_00003246_199704000_00019 crossref_primary_10_1152_ajpheart_2000_279_1_H35 crossref_primary_10_1111_j_1540_8167_1996_tb00505_x crossref_primary_10_1006_jmcc_2002_2053 crossref_primary_10_1098_rsob_120072 crossref_primary_10_1111_j_1540_8159_1997_tb06204_x crossref_primary_10_1111_j_1540_8167_1998_tb00916_x crossref_primary_10_1016_S0002_9149_98_00469_X crossref_primary_10_1016_S0002_8703_97_70072_3 crossref_primary_10_1371_journal_pone_0166143 |
ContentType | Journal Article |
Copyright | 1993 INIST-CNRS |
Copyright_xml | – notice: 1993 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1172/JCI116250 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1558-8238 |
EndPage | 701 |
ExternalDocumentID | 10_1172_JCI116250 8381826 4632303 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, U.S. Gov't, P.H.S Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: HL-43710 – fundername: NHLBI NIH HHS grantid: HL-32295 – fundername: NHLBI NIH HHS grantid: HL-41031 |
GroupedDBID | --- -~X .55 .GJ .XZ 08G 08P 08R 29K 2WC 354 36B 3O- 3V. 53G 5GY 5RE 5RS 7RV 7X7 88A 88E 8AO 8F7 8FE 8FH 8FI 8FJ 8R4 8R5 AAKAS AAUGY AAWTL AAYOK ABOCM ABPMR ABPTK ABUWG ACGFO ACIHN ACNCT ACPRK ADBBV ADZCM AEAQA AENEX AFCHL AFFNX AFKRA AHMBA AI. ALMA_UNASSIGNED_HOLDINGS AOIJS ASPBG AVWKF AZFZN BAWUL BBNVY BCR BCU BEC BENPR BHPHI BKEYQ BLC BPHCQ BVXVI CCPQU CS3 D-I DIK DU5 E3Z EBD EBS EJD EMB EMOBN EX3 F5P FEDTE FRP FYUFA GROUPED_DOAJ GX1 HCIFZ HYE H~9 IAO IEA IHR IHW INH INR IOF IOV IPO IQODW ISR J5H KQ8 L7B LK8 M0L M1P M5~ M7P MVM N4W NAPCQ OBH OCB ODZKP OFXIZ OGEVE OHH OHT OK1 OVD OVIDX P2P P6G PQQKQ PROAC PSQYO Q2X RPM S0X SJFOW SV3 TEORI TR2 TVE UHU UKHRP VH1 VVN W2D WH7 WOQ WOW X7M XSB YFH YHG YKV YOC ZA5 ZGI ZXP ZY1 ~H1 ALIPV CGR CUY CVF ECM EIF HMCUK HVGLF ITC NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c398t-ee93574a1c85c064487fd0476dcc772ecbcd030acd8d268017082d99a70ec6ce3 |
IEDL.DBID | RPM |
ISSN | 0021-9738 |
IngestDate | Tue Sep 17 21:15:53 EDT 2024 Fri Oct 25 04:43:47 EDT 2024 Thu Sep 26 17:37:09 EDT 2024 Sat Sep 28 07:38:29 EDT 2024 Sun Oct 29 17:09:13 EDT 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Heart Vertebrata Chemotherapy Experimental disease Mammalia Treatment Anesthetic Rat Animal Rodentia Antiarrhythmia agent Myocyte |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c398t-ee93574a1c85c064487fd0476dcc772ecbcd030acd8d268017082d99a70ec6ce3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://www.jci.org/articles/view/116250/files/pdf |
PMID | 8381826 |
PQID | 75562044 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_288011 proquest_miscellaneous_75562044 crossref_primary_10_1172_JCI116250 pubmed_primary_8381826 pascalfrancis_primary_4632303 |
PublicationCentury | 1900 |
PublicationDate | 1993-02-01 |
PublicationDateYYYYMMDD | 1993-02-01 |
PublicationDate_xml | – month: 02 year: 1993 text: 1993-02-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Ann Arbor, MI |
PublicationPlace_xml | – name: Ann Arbor, MI – name: United States |
PublicationTitle | The Journal of clinical investigation |
PublicationTitleAlternate | J Clin Invest |
PublicationYear | 1993 |
Publisher | American Society for Clinical Investigation |
Publisher_xml | – name: American Society for Clinical Investigation |
References | 2457460 - Circulation. 1988 Sep;78(3):692-700 2844438 - Circulation. 1988 Oct;78(4):1047-59 2418458 - Prog Biophys Mol Biol. 1985;46(3):163-83 2705385 - Am J Cardiol. 1989 May 1;63(15):1132-4 6255144 - J Physiol. 1980 Aug;305:215-34 6131381 - Nature. 1983 Feb 17-23;301(5901):569-74 2154132 - Am J Physiol. 1990 Jan;258(1 Pt 2):H247-54 2472462 - J Gen Physiol. 1989 May;93(5):841-54 2441262 - Nature. 1987 Aug 13-19;328(6131):634-7 6270629 - Pflugers Arch. 1981 Aug;391(2):85-100 6097678 - J Physiol. 1984 Nov;356:565-85 484500 - Am J Cardiol. 1979 Oct;44(4):705-13 2475783 - Nature. 1989 Aug 31;340(6236):718-21 6306139 - J Gen Physiol. 1983 May;81(5):613-42 1964722 - Pflugers Arch. 1990 Oct;417(2):142-8 3594771 - Circulation. 1987 Jul;76(1):226-36 2155070 - Circulation. 1990 Mar;81(3):1024-38 6486026 - Am J Cardiol. 1984 Oct 1;54(7):765-70 2553292 - Circ Res. 1989 Nov;65(5):1247-62 2434260 - Circulation. 1987 Mar;75(3):514-20 2768720 - J Am Coll Cardiol. 1989 Sep;14(3):705-11; discussion 712-4 1991354 - Circ Res. 1991 Feb;68(2):513-30 1309315 - Circ Res. 1992 Jan;70(1):199-207 4744693 - Am J Cardiol. 1973 Oct;32(5):629-36 240267 - Am Heart J. 1975 Oct;90(4):521-33 2343820 - Am J Cardiol. 1990 Jun 1;65(20):1328-33 2451006 - J Physiol. 1987 Oct;391:235-65 3554949 - Am J Cardiol. 1987 Apr 30;59(11):19E-25E 2158748 - Am J Physiol. 1990 Apr;258(4 Pt 2):H977-82 2826041 - Circ Res. 1988 Jan;62(1):162-72 14104166 - Circ Res. 1964 Jan;14:86-92 2436826 - Circ Res. 1987 Feb;60(2):206-19 2437787 - Am J Cardiol. 1987 Apr 30;59(11):26E-31E 7421912 - N Engl J Med. 1980 Nov 6;303(19):1073-7 2640462 - J Physiol. 1989 Aug;415:233-49 1081138 - J Pharmacol Exp Ther. 1975 Nov;195(2):225-36 207734 - J Clin Invest. 1978 May;61(5):1260-9 3940667 - Circulation. 1986 Jan;73(1):189-98 2543073 - Science. 1989 May 26;244(4907):983-5 2548633 - Biophys J. 1989 Jun;55(6):1261-6 3392332 - J Am Coll Cardiol. 1988 Aug;12(2):388-94 2846199 - Circ Res. 1988 Nov;63(5):869-78 |
References_xml | |
SSID | ssj0014454 |
Score | 1.5727994 |
Snippet | We demonstrated recently that isoproterenol enhanced the cardiac voltage-dependent sodium currents (INa) in rabbit ventricular myocytes through dual G-protein... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 693 |
SubjectTerms | Animals Antiarythmic agents Biological and medical sciences Cardiovascular system Cells, Cultured Heart - drug effects Heart - physiology Heart Conduction System - drug effects Isoproterenol - pharmacology Lidocaine - antagonists & inhibitors Medical sciences Membrane Potentials - drug effects Pharmacology. Drug treatments Rabbits Sodium Channels - drug effects |
Title | Reversal of lidocaine effects on sodium currents by isoproterenol in rabbit hearts and heart cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/8381826 https://search.proquest.com/docview/75562044 https://pubmed.ncbi.nlm.nih.gov/PMC288011 |
Volume | 91 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6aQEuglL5CnDatKL0664ce9rEsDWlgSykN5GakkUwNu_IS7x767zOytUu29NSb0QPsmTHzjfTpE8BnpbmRrRCpQKNTQsQmrXlYgOcY5OO4ymw44Lz4Lq9v-c2duIuHwoZIq_Rouku_XF367vfIrVyvcLbjic1-LOYFBV2ez47giOJzV6HHnQPORVReztNalVVUE6I8PbuZf8tzwvvZCTytQqYKigqPstHztR7IMO10o8W_IOffzMlHqejqJbyIGJJ9md71FTxx_jU8W8Rd8jdgfrpAtqAhfcuWnaV0Re0sUjdY79nQ2267YjiJMw3M_GHd0I-aDdTQL1nn2b02ptuwcOM1jdDeTo8sLPUPb-H26uuv-XUa71JIsayrTepcXQrFdY6VwCwUZaq1GVfSIhLAdmjQ0v-u0Va2kFVQ1akKW9daZQ4luvIUjn3v3RkwWRuCRVgoZw3HghukmkTWLebURgA0gU87mzbrSTKjGUsNVTR7FyRwcWDt_UguS6qKygQ-7qzfUMCHT9Pe9duhUUIEDX2ewOnki_3U6NME5IGT9v1BSfuwhwJsVNSeAur8fye-g5OJBxlYLu_heHO_dReEVTbmwxicD48P6wM |
link.rule.ids | 230,315,730,783,787,888,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7alLaBUvoKdds0ovTqrB962MeyNGzSbCglgdyMNZKJYVde4t1D_31HtnbJlp56M7IE9syI-Ub69Angq6q5lo0QsUBdx4SIdVxyvwDP0cvHcZUYf8B5fiVnN_ziVtyGQ2F9oFU61O2pWyxPXXs3cCtXS5xseWKTn_NpRkGXppPH8ISma8K3NXrYO-BcBO3lNC5VXgQ9IcrUk4vpeZoS4k8O4Wnhc5XXVHiQj16s6p5M04x3WvwLdP7NnXyQjM5ewcuAItm38WtfwyPr3sCzedgnfwv6l_V0C-rSNWzRGkpY1M4CeYN1jvWdaTdLhqM8U8_0b9b23aDaQA3dgrWO3ddat2vm77ymHrUz4yPzi_39O7g5-349ncXhNoUY87JYx9aWuVC8TrEQmPiyTDUm4UoaRILYFjUamvE1msJksvC6OkVmyrJWiUWJNj-CA9c5-x6YLDUBI8yUNZpjxjVSVSLLBlNqIwgawZetTavVKJpRDcWGyqqdCyI43rP2rieXOdVFeQQnW-tXFPL-12pnu01fKSG8ij6P4Gj0xW5o8GkEcs9Ju_deS3v_DYXYoKk9htSH_x14As9n1_PL6vL86sdHOBxZkZ7z8gkO1vcbe0zIZa0_D4H6BxNO7lk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7SlIZAKX2Fum0aUXp1_JIl-1i2XZK0G0JpIDcjjWRq2JWXePfQf9-RH0u29NSbkSWwZ0bMN9KnTwCfpOJa1Hke5qhVSIhYhyX3C_AcvXwcl7HxB5wX1-Lill_d5XcHUExnYXrSPurm3C1X56751XMr1yuMJp5YdLOYpRR0SRKtTR09gsc0ZWMx1enj_gHn-ai_nISlzIpRU4iydXQ1u0wSQv3xMTwpfL7yugoPctLTterIPPVwr8W_gOff_MkHCWn-HJ6NSJJ9Hr74BRxY9xKOFuNe-SvQP6ynXFCXtmbLxlDSonY2EjhY61jXmma7YjhINHVM_2ZN1_bKDdTQLlnj2L3Sutkwf-819VDODI_ML_h3r-F2_vXn7CIcb1QIMSuLTWhtmeWSqwSLHGNfmsnaxFwKg0gw26JGQ7NeoSlMKgqvrVOkpiyVjC0KtNkJHLrW2TfARKkJHGEqrdEcU66RKhNR1phQG8HQAD5ONq3Wg3BG1RccMq12LgjgdM_au55cZFQbZQGcTdavKOz9ryln221XyTz3Svo8gJPBF7uho08DEHtO2r33etr7byjMel3tIaze_u_AMzi6-TKvvl9ef3sHxwMx0tNe3sPh5n5rTwm8bPSHPk7_AH-S72w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reversal+of+lidocaine+effects+on+sodium+currents+by+isoproterenol+in+rabbit+hearts+and+heart+cells&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Lee%2C+H+C&rft.au=Matsuda%2C+J+J&rft.au=Reynertson%2C+S+I&rft.au=Martins%2C+J+B&rft.date=1993-02-01&rft.issn=0021-9738&rft.volume=91&rft.issue=2&rft.spage=693&rft_id=info:doi/10.1172%2FJCI116250&rft_id=info%3Apmid%2F8381826&rft.externalDocID=8381826 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9738&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9738&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9738&client=summon |